Jongkeun Park
Overview
Explore the profile of Jongkeun Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park J, Choi W, Seong D, Jeong S, Lee J, Park H, et al.
Elife
. 2024 Dec;
13.
PMID: 39717902
An unprecedented amount of SARS-CoV-2 data has been accumulated compared with previous infectious diseases, enabling insights into its evolutionary process and more thorough analyses. This study investigates SARS-CoV-2 features as...
2.
Choi W, Park J, Seong D, Chung D, Hong D
Genomics Inform
. 2024 Oct;
22(1):15.
PMID: 39380083
Many subtypes of SARS-CoV-2 have emerged since its early stages, with mutations showing regional and racial differences. These mutations significantly affected the infectivity and severity of the virus. This study...
3.
Park H, Park J, Woo H, Yun H, Lee M, Hong D
Cancer Res Treat
. 2024 Jun;
56(4):1027-1039.
PMID: 38853539
Purpose: In 2024, medical researchers in the Republic of Korea were invited to amend the health and medical data utilization guidelines (Government Publications Registration Number: 11-1352000-0052828-14). This study aimed to...
4.
Lee J, Park J, Hong D
Anim Cells Syst (Seoul)
. 2024 May;
28(1):216-227.
PMID: 38770056
Tyrosine kinase inhibitors (TKIs) have emerged as a potential treatment strategy for glioblastoma multiforme (GBM). However, their efficacy is limited by various drug resistance mechanisms. To devise more effective treatments...
5.
Seong D, Park J, Yi K, Hong D
Viruses
. 2023 Mar;
15(3).
PMID: 36992400
The pandemic has led to the production and accumulation of various types of data related to coronavirus disease 2019 (COVID-19). To understand the features and characteristics of COVID-19 data, we...
6.
Kim S, Joung J, Park W, Park J, Lee J, Park B, et al.
World J Mens Health
. 2023 Feb;
41(3):712-723.
PMID: 36792093
Purpose: This study aimed to identify metabolic genes associated with non-metastatic prostate cancer progression using The Cancer Genome Atlas (TCGA) datasets and validate their prognostic role by assessing patients' immunohistochemical...
7.
Kim S, Park J, Park W, Hong D, Chung J
Investig Clin Urol
. 2022 Nov;
63(6):602-611.
PMID: 36347549
Purpose: To identify candidate gene mutations to significantly predict the risk of survival prognosis after treatment with systemic first-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC) patients. Materials...
8.
Lee H, Lee A, Park W, Lee J, Park J, Park B, et al.
Front Oncol
. 2020 Nov;
10:556650.
PMID: 33194621
Background: To evaluate the role of epithelial splicing regulatory protein 1 (ESRP1) expression in survival prognoses and disease progression for prostate cancer (PC) using The Cancer Genome Atlas (TCGA) dataset...
9.
Paek A, Mun J, Jo M, Choi H, Lee Y, Cheong H, et al.
Cells
. 2019 Apr;
8(4).
PMID: 30935019
Autophagy is a cellular process that disrupts and uses unnecessary or malfunctioning components for cellular homeostasis. Evidence has shown a role for autophagy in tumor cell survival, but the molecular...
10.
Lee J, Lee A, Lee J, Park J, Kwon Y, Park S, et al.
Nucleic Acids Res
. 2018 May;
46(W1):W102-W108.
PMID: 29790943
Somatic genome mutations occur due to combinations of various intrinsic/extrinsic mutational processes and DNA repair mechanisms. Different molecular processes frequently generate different signatures of somatic mutations in their own favored...